Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Human medicine
Name of medicinal product: LORATADINE ACTAVIS
Active substances:
Estonian, English, Latin
ATC code: R06AX13
Dosage form: tablet
Strength: 10mg
Legal status for supply*: Subject to medicinal prescription, Not subject to medicinal prescription
Summary of product characteristics (SPC):  (last updated May 18, 2023)
Package information leaflet (PIL): EST  (last updated May 18, 2023)
Translation of package information leaflet into Russian: RUS  (last updated August 4, 2021)
Translation of package information leaflet into English: ENG  (last updated August 4, 2021)
Labelling:  (last updated May 18, 2023)
Indication: Symptomatic treatment of allergic rhinitis and idiopathic urticaria.
Safety features: Requiered on some packages, click on package code at the end of the page for more information
Marketing authorization holder: Teva B.V. 
Marketing authorization number: 423803 
Marketing authorization issued on: December 5, 2003 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: National 
Assessment report:   
Description Additional condition
Hambaarstil on õigus välja kirjutada
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1113747  LORATADINE ACTAVIS  tablet  10mg 10TK  OTC      15.02.2024     
1113758  LORATADINE ACTAVIS  tablet  10mg 30TK  Prescription           
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere